Next Step On the Innovation Pathway: Renal Disease Devices
By
Rebecca Kern / Email the Author / “The Gray Sheet” Jan. 23, 2012, Vol. 38, No. 04
Regulatory / Word Count: 941 / Article # 01120123007
Executive Summary
FDA issued an “innovation challenge” Jan. 12 asking companies developing devices for end-stage renal disease to volunteer for a pilot program designed to assess new statistical tools and collaborative processes that the agency hopes will accelerate product development.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.